Journal article icon

Journal article

Nutrition adequacy therapeutic enhancement in the critically ill: a randomized double‐blind, placebo‐controlled trial of the motilin receptor agonist camicinal (GSK962040): the NUTRIATE study

Abstract:

Background

Camicinal is a novel, nonmacrolide, motilin receptor agonist that accelerates gastric emptying in critically ill patients with established feed intolerance. The primary question was whether the preemptive administration of camicinal increased the provision of enteral nutrition (EN) to critically ill patients with risk factors that predisposed to feed intolerance.

Methods

This was an international, multicenter, parallel‐group...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/jpen.1038

Authors


More by this author
Role:
Author
ORCID:
0000-0002-7620-5577
Expand authors...
GlaxoSmithKline More from this funder
Publisher:
Wiley Publisher's website
Journal:
Journal of Parenteral and Enteral Nutrition Journal website
Volume:
42
Issue:
5
Pages:
949-959
Publication date:
2017-12-28
Acceptance date:
2017-10-16
DOI:
EISSN:
1941-2444
ISSN:
0148-6071
Pmid:
29957868
Source identifiers:
1033402
Language:
English
Keywords:
Pubs id:
pubs:1033402
UUID:
uuid:91af7d9e-62f8-4014-a8b0-2fca1553468c
Local pid:
pubs:1033402
Deposit date:
2019-07-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP